Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Income from Continuing Operations (2016 - 2025)

CorMedix's Income from Continuing Operations history spans 14 years, with the latest figure at 11776859.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 194.07% year-over-year to 11776859.0; the TTM value through Dec 2025 reached 137779507.0, up 829.96%, while the annual FY2025 figure was 137258000.0, 876.74% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 11776859.0 at CorMedix, down from 108562980.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 108562980.0 in Q3 2025 and bottomed at 14466123.0 in Q1 2024.
  • The 5-year median for Income from Continuing Operations is 7604839.0 (2022), against an average of 1423795.47.
  • The largest YoY upside for Income from Continuing Operations was 4002.28% in 2025 against a maximum downside of 194.07% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 9667173.0 in 2021, then increased by 15.03% to 8214498.0 in 2022, then dropped by 18.11% to 9702042.0 in 2023, then skyrocketed by 229.04% to 12519428.0 in 2024, then crashed by 194.07% to 11776859.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Income from Continuing Operations are 11776859.0 (Q4 2025), 108562980.0 (Q3 2025), and 20349488.0 (Q2 2025).